Free Trial

Parkside Investments LLC Has $933,000 Stake in Morgan Stanley (NYSE:MS)

Morgan Stanley logo with Finance background

Parkside Investments LLC boosted its stake in Morgan Stanley (NYSE:MS - Free Report) by 33.3% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,000 shares of the financial services provider's stock after purchasing an additional 2,000 shares during the quarter. Parkside Investments LLC's holdings in Morgan Stanley were worth $933,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Minot DeBlois Advisors LLC bought a new position in Morgan Stanley in the fourth quarter valued at about $25,000. IAG Wealth Partners LLC bought a new position in Morgan Stanley in the fourth quarter valued at about $28,000. Curio Wealth LLC bought a new position in Morgan Stanley in the fourth quarter valued at about $31,000. Ancora Advisors LLC grew its position in Morgan Stanley by 104.7% in the fourth quarter. Ancora Advisors LLC now owns 264 shares of the financial services provider's stock valued at $33,000 after acquiring an additional 135 shares during the last quarter. Finally, Crowley Wealth Management Inc. bought a new position in Morgan Stanley in the fourth quarter valued at about $34,000. Institutional investors and hedge funds own 84.19% of the company's stock.

Morgan Stanley Trading Down 1.9%

MS stock traded down $2.48 during trading on Friday, hitting $129.44. The company had a trading volume of 4,367,543 shares, compared to its average volume of 6,698,674. The business has a 50-day moving average of $121.25 and a 200-day moving average of $125.14. Morgan Stanley has a one year low of $90.94 and a one year high of $142.03. The stock has a market cap of $207.67 billion, a PE ratio of 16.30, a PEG ratio of 1.18 and a beta of 1.29. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 3.14.

Morgan Stanley (NYSE:MS - Get Free Report) last posted its quarterly earnings results on Friday, April 11th. The financial services provider reported $2.60 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.21 by $0.39. The firm had revenue of $17.74 billion for the quarter, compared to analysts' expectations of $16.81 billion. Morgan Stanley had a return on equity of 14.39% and a net margin of 12.48%. The company's revenue for the quarter was up 17.2% compared to the same quarter last year. During the same period in the prior year, the business earned $2.02 EPS. Research analysts predict that Morgan Stanley will post 8.56 earnings per share for the current fiscal year.

Morgan Stanley Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Wednesday, April 30th were issued a dividend of $0.925 per share. This represents a $3.70 dividend on an annualized basis and a dividend yield of 2.86%. The ex-dividend date of this dividend was Wednesday, April 30th. Morgan Stanley's payout ratio is 43.43%.

Insiders Place Their Bets

In other Morgan Stanley news, Director Robert H. Herz sold 800 shares of the stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $119.32, for a total transaction of $95,456.00. Following the transaction, the director now directly owns 96,760 shares in the company, valued at approximately $11,545,403.20. This represents a 0.82% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Eric F. Grossman sold 10,068 shares of the company's stock in a transaction that occurred on Tuesday, April 15th. The stock was sold at an average price of $111.65, for a total value of $1,124,092.20. Following the transaction, the insider now directly owns 199,274 shares in the company, valued at $22,248,942.10. The trade was a 4.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 50,868 shares of company stock worth $6,019,548. Corporate insiders own 0.19% of the company's stock.

Wall Street Analysts Forecast Growth

MS has been the topic of a number of recent analyst reports. Evercore ISI decreased their target price on Morgan Stanley from $150.00 to $138.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 1st. Wells Fargo & Company reduced their price target on Morgan Stanley from $130.00 to $120.00 and set an "equal weight" rating on the stock in a report on Monday, April 14th. Bank of America reduced their price target on Morgan Stanley from $150.00 to $144.00 and set a "buy" rating on the stock in a report on Wednesday, April 2nd. JMP Securities restated a "market perform" rating on shares of Morgan Stanley in a report on Monday, April 14th. Finally, Erste Group Bank upgraded Morgan Stanley from a "hold" rating to a "strong-buy" rating in a report on Saturday, May 24th. Eleven investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $133.23.

Read Our Latest Stock Report on Morgan Stanley

Morgan Stanley Company Profile

(Free Report)

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.

Featured Stories

Institutional Ownership by Quarter for Morgan Stanley (NYSE:MS)

Should You Invest $1,000 in Morgan Stanley Right Now?

Before you consider Morgan Stanley, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Morgan Stanley wasn't on the list.

While Morgan Stanley currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now
Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines